Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.16B |
| 2 |
Uber
UBER
|
+$452M |
| 3 |
Analog Devices
ADI
|
+$421M |
| 4 |
Walt Disney
DIS
|
+$376M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$375M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.55B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$430M |
| 4 |
NVIDIA
NVDA
|
+$368M |
| 5 |
JPMorgan Chase
JPM
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.78% |
| 2 | Healthcare | 3.27% |
| 3 | Industrials | 2.02% |
| 4 | Financials | 2.02% |
| 5 | Consumer Discretionary | 1.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4426
Southern Copper
SCCO
$162B
| $3.06M | ﹤0.01% |
51,299
+14,094
| +38% | +$717K |
|
|
SRCL
4427
CALL
DELISTED
Stericycle Inc
SRCL
| $3.06M | ﹤0.01% |
44,100
-14,900
| -25% | -$1.02M |
|
4428
American States Water
AWR
$3.48B
| $3.06M | ﹤0.01% |
38,428
+31,282
| +438% | +$2.4M |
|
|
SAFM
4429
CALL
DELISTED
Sanderson Farms Inc
SAFM
| $3.05M | ﹤0.01% |
23,100
+8,800
| +62% | +$1.16M |
|
4430
Brunswick
BC
$5.33B
| $3.05M | ﹤0.01% |
40,050
-63,490
| -61% | -$4.48M |
|
4431
PUT
Goodyear
GT
$1.74B
| $3.05M | ﹤0.01% |
279,600
+24,700
| +10% | +$249K |
|
4432
CALL
Tanger
SKT
$4.41B
| $3.05M | ﹤0.01% |
306,000
+7,800
| +3% | +$65.9K |
|
|
API
4433
CALL
Agora
API
$372M
| $3.05M | ﹤0.01% |
77,000
+50,100
| +186% | +$2.07M |
|
|
XEC
4434
PUT
DELISTED
CIMAREX ENERGY CO
XEC
| $3.05M | ﹤0.01% |
81,200
+21,000
| +35% | +$672K |
|
|
CPE
4435
CALL
DELISTED
Callon Petroleum Company
CPE
| $3.04M | ﹤0.01% |
230,592
+115,592
| +101% | +$998K |
|
|
RIDE
4436
PUT
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
| $3.03M | ﹤0.01% |
10,080
+9,180
| +1,020% | +$2.89M |
|
|
NIU
4437
CALL
Niu Technologies
NIU
$161M
| $3.03M | ﹤0.01% |
108,100
+97,900
| +960% | +$2.84M |
|
4438
ProShares Short S&P500
SH
$853M
| $3.03M | ﹤0.01% |
42,153
+17,253
| +69% | +$1.32M |
|
4439
AdaptHealth
AHCO
$775M
| $3.03M | ﹤0.01% |
80,584
-72,410
| -47% | -$2.24M |
|
|
API
4440
PUT
Agora
API
$372M
| $3.03M | ﹤0.01% |
76,500
+12,400
| +19% | +$512K |
|
4441
PUT
BioCryst Pharmaceuticals
BCRX
$2.54B
| $3.02M | ﹤0.01% |
405,600
+139,500
| +52% | +$719K |
|
|
CS
4442
PUT
DELISTED
Credit Suisse Group
CS
| $3.02M | ﹤0.01% |
236,000
+64,100
| +37% | +$743K |
|
|
BBT
4443
PUT
Beacon Financial Corp
BBT
$2.73B
| $3.02M | ﹤0.01% |
176,400
+166,400
| +1,664% | +$2.48M |
|
4444
CALL
Invesco CurrencyShares Canadian Dollar Trust
FXC
$70.4M
| $3.02M | ﹤0.01% |
39,000
-52,300
| -57% | -$3.95M |
|
4445
PUT
MillerKnoll
MLKN
$1.59B
| $3.02M | ﹤0.01% |
89,200
+63,900
| +253% | +$2.22M |
|
4446
PUT
Microvision
MVIS
$50.9M
| $3.01M | ﹤0.01% |
37,340
+32,727
| +709% | +$1.44M |
|
4447
CALL
Cal-Maine
CALM
$3.77B
| $3.01M | ﹤0.01% |
80,200
+31,900
| +66% | +$1.23M |
|
|
TRPA
4448
Hartford AAA CLO ETF
TRPA
$111M
| $3.01M | ﹤0.01% |
73,051
-5,306
| -7% | -$218K |
|
4449
PUT
Huntsman Corp
HUN
$1.81B
| $3M | ﹤0.01% |
119,500
-404,400
| -77% | -$10M |
|
|
SINA
4450
PUT
DELISTED
Sina Corp
SINA
| $3M | ﹤0.01% |
70,800
-73,800
| -51% | -$3.17M |
|
Similar funds
Ken Griffin's Q4 2020 Portfolio in Review
As of Q4 2020, Ken Griffin held 11,975 positions worth $385B, up 9.1% from $353B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin withdrew a net $35.1B in Q4 2020, closing 1,130 positions and reducing 4,218 holdings. Its most notable exit was Immunomedics Inc, an estimated $213M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, up from 3% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ken Griffin opened a new position in S&P Global worth $114M.
- Ken Griffin's largest Q4 2020 buy was S&P Global: 345,785 shares worth $114M.
- Ken Griffin added most to iShares Core S&P 500 ETF in Q4 2020, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2020 reduction was Amazon, cutting an estimated $1.55B.
- Ken Griffin fully exited Immunomedics Inc in Q4 2020, selling an estimated $213M.
- Ken Griffin's ten largest holdings make up 31% of its $385B portfolio in Q4 2020.
- Ken Griffin opened 1,988 new positions and closed 1,130 in Q4 2020.
- Ken Griffin's portfolio value rose 9.1% quarter-over-quarter to $385B.
Based on Citadel Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.